Loading...

Opiant Pharmaceuticals, Inc.

OPNTNASDAQ
Healthcare
Biotechnology
$20.65
$0.00(0.00%)

Opiant Pharmaceuticals, Inc. (OPNT) Company Profile & Overview

Explore Opiant Pharmaceuticals, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Opiant Pharmaceuticals, Inc. (OPNT) Company Profile & Overview

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

SectorHealthcare
IndustryBiotechnology
CEORoger Crystal

Contact Information

310 598 5410
233 Wilshirre Boulevard, Santa Monica, CA, 90401

Company Facts

37 Employees
IPO DateJun 4, 2007
CountryUS

Frequently Asked Questions

;